Supply Chain

 Here are the four latest medical device recalls compiled on Becker’s Hospital Review, starting with the most recent.

Adopting an advanced inventory management system reduced the costs of medical and surgical tools used in the operating room, according to a study released by the Center for Innovation and Healthcare Logistics at the University of Arkansas in Fayetteville.

The global drug device combination products market is expected to reach $115.1 billion by 2019, growing at a compound annual growth rate of 7.9 percent, according to a news release.

Healthcare organizations are starting to look at the supply chain as a strategic cost saving tool instead of just a daily operational process. Here are five tips to reduce supply chain cost, as reported by Healthcare Global.

Synergy Health and the University of South Florida Health Center for Advanced Medical Learning and Simulation, both in Tampa, Fla., have entered into partnership where Synergy Health will be the sole provider of surgical instrument processing for CAMLS as well…

Abrams Royal Pharmacy in Dallas has issued a voluntary recall on all lots of unexpired sterile products, citing a lack of sterility assurance.

The U.S. Food and Drug Administration and the European Medicines Agency have launched a joint initiative to share information on bioequivalence studies in generic drug approval applications.

The U.S. Food and Drug Administration and CMS announced an extension on their joint Parallel Review pilot program, according to a Regulatory Focus report.

The U.S. Food and Drug Administration has named Lawrenceville, N.J.-based GS1 US the first accredited issuing agency for unique device identifiers, according to a news release.

The U.S. Food and Drug Administration, Center for Devices and Radiological Health, has announced improvements to the medical device recalls database.